• Filipin III for Membrane Cholesterol Visualization

  2026-08-13

  Filipin III converts membrane cholesterol distribution into an interpretable fluorescence or ultrastructural readout for cell, vesicle, and membrane-fraction studies. This workflow connects cholesterol imaging with recent macrophage immunometabolism research while emphasizing controls, sample handling, and assay limitations.

• IEM 1460: AMPA Receptor Blocker for Neuroprotection

  2026-08-13

  IEM 1460 provides a selective way to isolate AMPA receptor contributions in synaptic transmission, excitotoxicity, and neuronal survival assays. Its DMSO solubility and research-grade format support controlled dose-response, electrophysiology, calcium-imaging, and neuroprotection workflows.

• Viral RIPK3 Degradation and Inflammation

  2026-08-12

  Liu et al. identified a cowpox virus protein family that hijacks the host SCF ubiquitin ligase machinery to drive proteasomal degradation of RIPK3, thereby suppressing necroptosis while promoting viral replication and inflammation. The study connects viral immune evasion with pathogen–host evolution and provides a framework for testing how proteasome-dependent protein turnover shapes inflammatory infection biology.

• Cy3 NHS ester (non-sulfonated): Practical Guide

  2026-08-12

  Cy3 NHS ester (non-sulfonated), SKU A8100, provides a water-insoluble NHS ester reagent for covalent fluorescent labeling of primary amino groups on proteins, peptides, and amino-modified oligonucleotides. It is appropriate for workflows that can tolerate a DMSO or DMF co-solvent, but it is not suitable for strictly aqueous labeling or long-term storage of dye solutions.

• DCPS, m7G, and Epithelial Repair in Diabetic Foot Ulcers

  2026-08-11

  A 2025 World Journal of Diabetes study identifies the decapping scavenger enzyme DCPS as an N7-methylguanosine-related biomarker associated with impaired epithelial repair in diabetic foot ulcers. Integrating transcriptomic analysis with keratinocyte experiments, the study links reduced DCPS to altered cell-cycle progression, lower proliferation and migration, and increased apoptosis, while also defining important limitations for clinical translation.

• Recombinant Human FGF-19 in AKI Research

  2026-08-11

  Use Recombinant Human FGF-19 as a controlled FGFR4/β-Klotho perturbation in metabolic, signaling, and exploratory kidney-injury assays. This workflow combines validated protein handling with p38 MAPK and pyroptosis readouts inspired by recent sepsis-associated AKI research.

• Cefazedone (Refosporen): From PBP Biology to Impact

  2026-08-10

  Cefazedone (Refosporen) offers a useful translational model for connecting penicillin-binding protein biology, resistance-aware antibacterial testing, and time-dependent pharmacodynamics. This thought-leadership analysis shows how researchers can move beyond a product-page description toward better assay design, comparative benchmarking, and clinically meaningful interpretation.

• Ceftolozane Sulfate: Assay Workflows & PK/PD

  2026-08-09

  Build reproducible susceptibility, time-kill, and PK/PD experiments around Ceftolozane sulfate without confusing salt-form handling with combination-drug data. This workflow also shows how resistant-isolate surveillance can sharpen strain selection and interpretation for Pseudomonas aeruginosa studies.

• Biotin-16-UTP for lncRNA Assays

  2026-08-08

  Learn how Biotin-16-UTP supports traceable RNA synthesis, streptavidin capture, RNA-protein interaction studies, and localization workflows. A practical workflow connects these capabilities to RNASEH1-AS1 research in hepatocellular carcinoma while emphasizing controls, optimization, and assay limitations.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-08-07

  A 2025 study identified an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses SASP-related inflammation in macrophage-derived foam cells and ApoE-deficient mice. Its combination of plaque phenotyping, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown links nuclear-receptor activity to ubiquitin-mediated regulation of the GATA4/p62 complex.

• HyperScribe T7 High Yield RNA Synthesis Kit: Precision RNA S

  2026-08-07

  The HyperScribe™ T7 High Yield RNA Synthesis Kit empowers researchers with rapid, high-yield, and customizable in vitro RNA synthesis for demanding applications such as CRISPR-based gene editing and RNA vaccine development. With robust yields and flexible support for capped, dye-labeled, and biotinylated RNA, this kit streamlines complex workflows while maintaining reproducibility and purity.

• Minocycline HCl in Scalable EV Biomanufacturing Workflows

  2026-08-06

  Minocycline HCl empowers scalable, reproducible biomanufacturing workflows by leveraging its antibacterial and anti-inflammatory mechanisms for enhanced extracellular vesicle (EV) quality and yield. This guide details applied experimental protocols, troubleshooting strategies, and cross-study insights for researchers advancing regenerative medicine and neuroinflammation models.

• AM251: Advancing Translational Cannabinoid Research with Mec

  2026-08-06

  Explore how AM251, a potent CB1 receptor antagonist, empowers translational researchers to dissect endocannabinoid signaling and model complex neuroimmune and metabolic phenotypes. This article bridges mechanistic insights with protocol guidance, situates AM251 within the competitive landscape, and offers a strategic perspective on its role in advancing cannabinoid receptor research beyond conventional applications.

• Regulation and Enhancement of A40926 Glycopeptide Production

  2026-08-05

  Yushchuk et al. developed new genetic tools to improve glycopeptide antibiotic (A40926) yields in Nonomuraea gerenzanensis. By validating promoter systems and overexpressing pathway-specific regulatory genes, they achieved significant increases in antibiotic production, offering valuable strategies for optimizing industrial biosynthesis of clinically important compounds like dalbavancin.

• Paclitaxel (Taxol): Mechanisms, Benchmarks, and Research Lim

  2026-08-05

  Paclitaxel (Taxol) is a microtubule stabilizer widely used in cancer research to induce cell cycle arrest at the G2-M phase. It demonstrates high potency and selectivity in antitumor models, with robust literature and product data supporting its use. This article clarifies its mechanism, evidence, and limitations for reproducible oncology workflows.

16362 records 1/1091 page Next 12345 下5页 Last page